{"id":"W3132531164","doi":"10.3324/haematol.2020.271304","title":"Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia","year":2021,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"National Institutes of Health; Canadian Institutes of Health Research; Centre hospitalier régional universitaire de Lille; Medizinische Universität Wien; Oesterreichische Nationalbank; Universität Wien; Centre Hospitalier Universitaire de Québec; Austrian Science Fund; Institut National de la Santé et de la Recherche Médicale; Broad Institute; Université de Lille; Centre National de la Recherche Scientifique; Österreichischen Akademie der Wissenschaften; Vienna Science and Technology Fund; Université Laval","keywords":"Venetoclax; Ibrutinib; Prolymphocytic leukemia; Medicine; Leukemia; Oncology; Cancer research; Internal medicine; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002781117,0.0006162787,0.001337492,0.0008392624,0.002217074,0.003331078,0.001588829,0.02368738,0.006192075],"category_scores_gemma":[0.009049007,0.0004676237,0.001459168,0.000557682,0.002586565,0.001900812,0.001046002,0.03128381,0.004961626],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004818486,"about_ca_system_score_gemma":0.003531571,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001645038,"about_ca_topic_score_gemma":0.00392539,"domain_scores_codex":[0.9980077,0.0006747022,0.0002110553,0.0003039918,0.0005121375,0.0002904053],"domain_scores_gemma":[0.9968701,0.001731392,0.0002143348,0.0001047885,0.0004557316,0.00062365],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007157266,0.0002199609,0.002359724,0.0002291696,0.0000922225,0.01513598,0.0002017597,0.001151732,0.001732832,0.05759326,0.8615995,0.05896821],"study_design_scores_gemma":[0.001107097,0.0004054553,0.001779641,0.0008656852,0.0001025144,0.01202599,0.0002436181,0.001725788,0.0009606147,0.0572623,0.9234276,0.00009363086],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.00149805,0.006231247,0.0006019862,0.9638149,0.01194796,0.00005782256,0.0001066012,0.00004952585,0.01569194],"genre_scores_gemma":[0.03123024,0.006214364,0.002000256,0.8546374,0.08815509,0.0002302144,0.0001313337,0.00005270984,0.01734842],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.02368738,"threshold_uncertainty_score":0.03496069,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05991853302489981,"score_gpt":0.3106550916494875,"score_spread":0.2507365586245877,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}